Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults

NCT01701752 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A

Interventions

BIOLOGICAL: FP-01.1 + Placebo
BIOLOGICAL: FP-01.1 + TIV
BIOLOGICAL: FP-01.1-Adjuvant + Placebo
BIOLOGICAL: FP-01.1-Adjuvant + TIV
BIOLOGICAL: Adjuvant + TIV
BIOLOGICAL: Placebo + TIV
BIOLOGICAL: FP-01.1
BIOLOGICAL: FP-01.1-Adjuvant
OTHER: Placebo

Sponsor

Immune Targeting Systems Ltd